EUVIMEDEUVIMED entdecken
Crossref

Unraveling preeclampsia: Is the fibrinogen‐to‐albumin ratio the key to early risk assessment?

Uğurcan Zorlu iD, Osman Onur Özkavak iD, Hakkı Şerbetçi iD, Esra Karataş iD, Gülcan Okutucu iD, Atakan Tanaçan iD, Özgür Kara iD, Dilek Şahin iD

International Journal of Gynecology & Obstetrics · 2026-03 · 172 (3) · 1553-1560

DOI: 10.1002/ijgo.70510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 01.09.2025. Verfasst von Uğurcan Zorlu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatalogy, Ankara Bilkent City Hospital, Ankara, Turkey. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Preeclampsia is a significant cause of maternal and neonatal morbidity and mortality. Early prediction is crucial for improving perinatal outcomes and enabling timely prophylactic interventions. This study aims to evaluate the predictive value of the fibrinogen‐to‐albumin ratio (FAR) in the first trimester for preeclampsia, its severity, and associated adverse pregnancy outcomes.

Methods

This retrospective cohort study was conducted at the Perinatology Clinic of Bilkent City Hospital between January 2022 and April 2022. The records of 2116 pregnant women who underwent first‐trimester combined screening at 12 weeks of gestation were reviewed, and after applying exclusion criteria, 112 women diagnosed with preeclampsia were identified. An equal number of normotensive pregnant women were randomly selected as controls from the same hospital database within the same period. Maternal blood samples were analyzed for fibrinogen and albumin levels, and the FAR was calculated. Clinical and neonatal outcomes were recorded. Statistical analyses included independent t ‐tests, χ 2 ‐tests, receiver operating characteristic (ROC) curve analysis, and logistic regression modeling to evaluate the predictive value of FAR for preeclampsia.

Results

Fibrinogen levels were significantly higher in the preeclampsia group (4.64 ± 1.21 g/L) compared to controls (3.94 ± 0.97 g/L, P = 0.032). The FAR was also significantly elevated in the preeclampsia group (0.128 ± 0.04) versus controls (0.106 ± 0.03, P = 0.012). ROC analysis demonstrated good predictive performance for FAR in identifying preeclampsia (area under the curve [AUC]: 0.79; sensitivity: 86.1%, specificity: 70.6%) and severe preeclampsia (AUC: 0.83; sensitivity: 88.6%, specificity: 74.5%). Higher FAR was significantly associated with an increased risk of placental abruption (odds ratio [OR]: 2.1, P = 0.018), neonatal respiratory distress syndrome (OR: 2.25, P = 0.017), and neonatal intensive care unit admission (OR: 2.19, P = 0.018).

Conclusion

The FAR is a promising biomarker for the early prediction of preeclampsia, its severity, and adverse perinatal outcomes. Given its accessibility, affordability, and strong predictive value, FAR could be integrated into first‐trimester screening protocols alongside existing markers to improve early risk stratification. Further multi‐center validation studies are recommended to optimize predictive models for clinical use.

Schlagwörter

Stichwörter der Autor:innen

aspirin prophylaxisearly predictionfibrinogen/albumin ratiofirst trimestermaternal outcomesneonatal outcomespreeclampsiapregnancy biomarkersrisk stratification

Autor:innen und Institutionen

  • Department of Perinatalogy, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Department of Perinatalogy, University of Health Sciences, Ankara, Turkey.

ORCID-Profile: Uğurcan Zorlu, Osman Onur Özkavak, Hakkı Şerbetçi, Esra Karataş, Gülcan Okutucu, Atakan Tanaçan, Özgür Kara, Dilek Şahin

Zitieren

APA

Zorlu, U., Özkavak, O. O., Şerbetçi, H., Karataş, E., Okutucu, G., Tanaçan, A., Kara, Ö., & Şahin, D. (2026). Unraveling preeclampsia: Is the fibrinogen‐to‐albumin ratio the key to early risk assessment?. International Journal of Gynecology & Obstetrics, 172(3), 1553-1560. https://doi.org/10.1002/ijgo.70510

Vancouver

Zorlu U, Özkavak OO, Şerbetçi H, Karataş E, Okutucu G, Tanaçan A, et al. Unraveling preeclampsia: Is the fibrinogen‐to‐albumin ratio the key to early risk assessment?. International Journal of Gynecology & Obstetrics. 2026;172(3):1553-1560. doi:10.1002/ijgo.70510

BibTeX
@article{Zorlu2026,
  author = {Zorlu, Uğurcan and Özkavak, Osman Onur and Şerbetçi, Hakkı and Karataş, Esra and Okutucu, Gülcan and Tanaçan, Atakan and Kara, Özgür and Şahin, Dilek},
  title = {Unraveling preeclampsia: Is the fibrinogen‐to‐albumin ratio the key to early risk assessment?},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  volume = {172},
  number = {3},
  pages = {1553--1560},
  doi = {10.1002/ijgo.70510}
}
Kostenlos starten →